期刊文献+

利多卡因醇质体的组方研究及其包封率测定 被引量:4

Investigation on Optimal Formula of Lidocaine Ethosome and Determination of Its Entrapment Efficiency
下载PDF
导出
摘要 目的:研究制备5%利多卡因醇质体的最佳组方,并对其包封率进行测定。方法:采用正交实验设计设定5%利多卡因醇质体的组方并采用超声注入法进行制备;结合透析袋平衡透析法及高效液相色谱(HPLC)法测定各组方醇质体的包封率,以包封率为评价指标筛选出最佳组方。结果:5%利多卡因醇质体的最佳组方构成为:5%的利多卡因、35%的无水乙醇、5%蛋黄卵磷脂、0.2%的胆固醇及54.8%的超纯水;所制备5%利多卡因醇质体的包封率为(52.85±0.36)%。结论:本研究所采用的制备5%利多卡因及其包封率测定的方法简便、快速、准确,所制备的利多卡因醇质体的包封率较为理想,从而为相关后续研究奠定了基础。 Objective:To obtain optimal formula of 5% lidocaine ethosome with high entrapment efficiency. Methods:The orthogonal test was used to design the formula of 5% lidocaine ethosome which was prepared with ultrasonic injection method.The balanced dialysis with high performance liquid chromatogram(HPLC) analysis methods were used to determine the entrapment efficiency of lidocaine ethosome.The optimal formula of 5% lidocaine ethosome was selected by the highest entrapment efficiency. Results:The optimal formula of 5% lidocaine ethosome was 35% anhydrous ethanol、5% egg phosphatide and 0.2% cholesterol.The entrapment efficiency was 52.85±0.36%. Conclusion:The preparation technique was with ease and convenient,and entrapment efficiency determination method of 5% lidocaine ethosome were accurate.The entrapment efficiency of lidocaine ethosome was ideal which will facilitate the research work in the next stage.
出处 《皮肤性病诊疗学杂志》 2011年第1期26-29,共4页 Journal of Diagnosis and Therapy on Dermato-venereology
基金 国家自然科学基金(30902019)
关键词 利多卡因 醇质体 HPLC Lidocaine Ethosome HPLC
  • 相关文献

参考文献10

  • 1Sintov AC, Shapiro L. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo [ J ]. J Control Release, 2004,95 (2) :173-183.
  • 2Mustafa MA, Ossama AY, Viviane NF. Lipid vesicles for skin delivery of drugs: Reviewing three decades of research [ J]. International Journal of Pharmaceutics ,2007, 332 : 1-16.
  • 3Touitou E, Dayan N. Ethosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration properties [ J ]. Journal of Controlled Release, 2000,65:403-418.
  • 4Vaibhav D, Dinesh M ,Tathagata D. Melatonin loaded ethanolic liposomes: Physicochemical characterization and enhanced transdermal delivery [ J ]. European JoumaF of Pharmaceutics and Biopharmaceutics,2007 ,67 :398-405.
  • 5杨效宇,赵佩,李兰兰,焦海胜.两种秋水仙碱醇质体的制备及评价[J].中国药学杂志,2010,45(11):844-848. 被引量:7
  • 6Donatella P, Giuseppe D, Domenico M,et al. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers [ J ]. Journal of Controlled Release, 2005,106:99-110.
  • 7Subheet J, Ashok KT, Bharti S. Formulation and Evaluation of Ethosomes for Transdermal Delivery of Lamivudine [ J]. AAPS PharmSciTech, 2007,4( 8 ): 111.
  • 8Zhao WZ. Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats[ J]. J Liposome Res ,2009,24 : 1-8.
  • 9Tadros MI, Ehab R. Enhanced Transdermal Delivery of Salbutamol Sulfate via Ethosomes [ J ]. AAPS Pharm- SciTech, 2007,4 ( 8 ) : 107.
  • 10Lopez-Pinto JM, Gonzalea-Rodriguez ML. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes [ J ]. International Journal of Pharmaceutics, 2005, 298 : 1-12.

二级参考文献4

共引文献6

同被引文献70

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部